Evidence map›Paper›PMID 30707252›Full record

ReviewApplied microbiology and biotechnology2019

Biotechnological production of glycolic acid and ethylene glycol: current state and perspectives.

Laura Salusjärvi, Sami Havukainen, Outi Koivistoinen, Mervi Toivari

Open access · hybridAbstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 138 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Biotransformation of ethylene glycol by engineeredSynthetic and systems biotechnology · 2024
    Article
  13. Article
  14. Novel aspects of ethylene glycol catabolism.Applied microbiology and biotechnology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Phytochemical Screening and Biological Properties ofMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Laura SalusjärviSolutions for Natural Resources and Environment, VTT Technical Research Centre of Finland Ltd, Tietotie 2, P.O. Box 1000, 02044 VTT, Espoo, Finland. laura.salusjarvi@vtt.fi.ORCID http://orcid.org/0000-0002-2265-6778
Sami HavukainenSolutions for Natural Resources and Environment, VTT Technical Research Centre of Finland Ltd, Tietotie 2, P.O. Box 1000, 02044 VTT, Espoo, Finland.
Outi KoivistoinenSolutions for Natural Resources and Environment, VTT Technical Research Centre of Finland Ltd, Tietotie 2, P.O. Box 1000, 02044 VTT, Espoo, Finland.
Mervi ToivariSolutions for Natural Resources and Environment, VTT Technical Research Centre of Finland Ltd, Tietotie 2, P.O. Box 1000, 02044 VTT, Espoo, Finland.
Tieto (Finland) · FI

Funding

Academy of Finland 118573
6 · The paper itself

Abstract

Glycolic acid (GA) and ethylene glycol (EG) are versatile two-carbon organic chemicals used in multiple daily applications. GA and EG are currently produced by chemical synthesis, but their biotechnological production from renewable resources has received a substantial interest. Several different metabolic pathways by using genetically modified microorganisms, such as Escherichia coli, Corynebacterium glutamicum and yeast have been established for their production. As a result, the yield of GA and EG produced from sugars has been significantly improved. Here, we describe the recent advancement in metabolic engineering efforts focusing on metabolic pathways and engineering strategies used for GA and EG production.

Indexed as

Metabolic EngineeringMetabolic Networks and PathwaysCorynebacterium glutamicumEscherichia coliEthylene GlycolGlycolatesIndustrial MicrobiologyMicroorganisms, Genetically-ModifiedSaccharomyces cerevisiaeXyloseEthylene GlycolGlycolatesglycolic acidXyloseBiorefineryBiotechnologyDahms pathwayD-ribulose-1-phosphate pathwayD-xyloseD-xylulose-1-phosphate pathwayEthylene glycolGlycolic acidGlyoxylate shuntL-xylulose-1-phosphate pathwayMetabolic engineeringSerine pathway

Identifiers

PMID30707252
PMCPMC6443609
OpenAlexW2913683772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.